vs

Side-by-side financial comparison of CPS TECHNOLOGIES CORP (CPSH) and Linde plc (LIN). Click either name above to swap in a different company.

Linde plc is the larger business by last-quarter revenue ($8.8M vs $8.2M, roughly 1.1× CPS TECHNOLOGIES CORP). On growth, CPS TECHNOLOGIES CORP posted the faster year-over-year revenue change (38.3% vs 8.2%). Linde plc produced more free cash flow last quarter ($898.0K vs $-487.0K). Over the past eight quarters, CPS TECHNOLOGIES CORP's revenue compounded faster (17.8% CAGR vs -96.7%).

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

Linde is a global multinational chemical company and the world's largest industrial gas supplier by market share and revenue. Founded by German scientist and engineer Carl von Linde in 1879 in Wiesbaden, Germany, the company is now headquartered in Woking, United Kingdom, and registered in Ireland as Linde plc. Linde plc was formed in 2018 through the merger of Linde AG and Praxair, which was founded in 1907 in the United States as Linde Air Products Company.

CPSH vs LIN — Head-to-Head

Bigger by revenue
LIN
LIN
1.1× larger
LIN
$8.8M
$8.2M
CPSH
Growing faster (revenue YoY)
CPSH
CPSH
+30.1% gap
CPSH
38.3%
8.2%
LIN
More free cash flow
LIN
LIN
$1.4M more FCF
LIN
$898.0K
$-487.0K
CPSH
Faster 2-yr revenue CAGR
CPSH
CPSH
Annualised
CPSH
17.8%
-96.7%
LIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CPSH
CPSH
LIN
LIN
Revenue
$8.2M
$8.8M
Net Profit
$12.6K
Gross Margin
14.9%
48.5%
Operating Margin
-1.2%
27.8%
Net Margin
0.2%
Revenue YoY
38.3%
8.2%
Net Profit YoY
101.3%
EPS (diluted)
$0.00
$3.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSH
CPSH
LIN
LIN
Q1 26
$8.8M
Q4 25
$8.2M
$8.8B
Q3 25
$8.8M
$8.6B
Q2 25
$8.1M
$8.5B
Q1 25
$7.5M
$8.1B
Q4 24
$5.9M
$8.3B
Q3 24
$4.2M
$8.4B
Q2 24
$5.0M
$8.3B
Net Profit
CPSH
CPSH
LIN
LIN
Q1 26
Q4 25
$12.6K
$1.5B
Q3 25
$208.0K
$1.9B
Q2 25
$103.8K
$1.8B
Q1 25
$96.0K
$1.7B
Q4 24
$-995.2K
$1.7B
Q3 24
$-1.0M
$1.6B
Q2 24
$-954.3K
$1.7B
Gross Margin
CPSH
CPSH
LIN
LIN
Q1 26
48.5%
Q4 25
14.9%
Q3 25
17.1%
Q2 25
16.5%
Q1 25
16.4%
Q4 24
-4.6%
Q3 24
-12.3%
Q2 24
-4.6%
Operating Margin
CPSH
CPSH
LIN
LIN
Q1 26
27.8%
Q4 25
-1.2%
23.0%
Q3 25
3.1%
27.5%
Q2 25
1.7%
27.7%
Q1 25
1.7%
26.9%
Q4 24
-22.2%
27.4%
Q3 24
-35.0%
25.0%
Q2 24
-26.1%
26.4%
Net Margin
CPSH
CPSH
LIN
LIN
Q1 26
Q4 25
0.2%
17.5%
Q3 25
2.4%
22.4%
Q2 25
1.3%
20.8%
Q1 25
1.3%
20.6%
Q4 24
-16.8%
20.8%
Q3 24
-24.6%
18.5%
Q2 24
-19.0%
20.1%
EPS (diluted)
CPSH
CPSH
LIN
LIN
Q1 26
$3.98
Q4 25
$0.00
$3.28
Q3 25
$0.01
$4.09
Q2 25
$0.01
$3.73
Q1 25
$0.01
$3.51
Q4 24
$-0.07
$3.61
Q3 24
$-0.07
$3.22
Q2 24
$-0.07
$3.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSH
CPSH
LIN
LIN
Cash + ST InvestmentsLiquidity on hand
$13.2M
$4.0M
Total DebtLower is stronger
$24.7M
Stockholders' EquityBook value
$24.6M
$40.1M
Total Assets
$29.5M
$86.3M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSH
CPSH
LIN
LIN
Q1 26
$4.0M
Q4 25
$13.2M
$5.1B
Q3 25
$4.3M
$4.5B
Q2 25
$3.4M
$4.8B
Q1 25
$3.0M
$5.3B
Q4 24
$4.3M
$4.8B
Q3 24
$5.7M
$5.2B
Q2 24
$7.1M
$4.6B
Total Debt
CPSH
CPSH
LIN
LIN
Q1 26
$24.7M
Q4 25
$20.7B
Q3 25
$18.6B
Q2 25
$19.7B
Q1 25
$17.6B
Q4 24
$8.1K
$15.3B
Q3 24
$20.1K
$17.5B
Q2 24
$31.9K
$16.9B
Stockholders' Equity
CPSH
CPSH
LIN
LIN
Q1 26
$40.1M
Q4 25
$24.6M
$38.2B
Q3 25
$15.1M
$38.6B
Q2 25
$14.9M
$38.5B
Q1 25
$14.7M
$38.0B
Q4 24
$14.5M
$38.1B
Q3 24
$15.4M
$39.2B
Q2 24
$16.4M
$38.2B
Total Assets
CPSH
CPSH
LIN
LIN
Q1 26
$86.3M
Q4 25
$29.5M
$86.8B
Q3 25
$20.4M
$86.0B
Q2 25
$19.4M
$86.1B
Q1 25
$19.2M
$82.7B
Q4 24
$18.9M
$80.1B
Q3 24
$19.2M
$82.5B
Q2 24
$20.1M
$80.2B
Debt / Equity
CPSH
CPSH
LIN
LIN
Q1 26
0.62×
Q4 25
0.54×
Q3 25
0.48×
Q2 25
0.51×
Q1 25
0.46×
Q4 24
0.00×
0.40×
Q3 24
0.00×
0.45×
Q2 24
0.00×
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSH
CPSH
LIN
LIN
Operating Cash FlowLast quarter
$243.6K
Free Cash FlowOCF − Capex
$-487.0K
$898.0K
FCF MarginFCF / Revenue
-5.9%
10.2%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-479.6K
$4.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSH
CPSH
LIN
LIN
Q1 26
Q4 25
$243.6K
$3.0B
Q3 25
$1.1M
$2.9B
Q2 25
$649.3K
$2.2B
Q1 25
$-1.3M
$2.2B
Q4 24
$-3.5M
$2.8B
Q3 24
$-1.2M
$2.7B
Q2 24
$-1.0M
$1.9B
Free Cash Flow
CPSH
CPSH
LIN
LIN
Q1 26
$898.0K
Q4 25
$-487.0K
$1.6B
Q3 25
$876.8K
$1.7B
Q2 25
$476.4K
$954.0M
Q1 25
$-1.3M
$891.0M
Q4 24
$-4.5M
$1.6B
Q3 24
$-1.3M
$1.7B
Q2 24
$-1.6M
$796.0M
FCF Margin
CPSH
CPSH
LIN
LIN
Q1 26
10.2%
Q4 25
-5.9%
17.9%
Q3 25
10.0%
19.4%
Q2 25
5.9%
11.2%
Q1 25
-17.9%
11.0%
Q4 24
-75.3%
18.8%
Q3 24
-29.8%
19.9%
Q2 24
-31.8%
9.6%
Capex Intensity
CPSH
CPSH
LIN
LIN
Q1 26
Q4 25
8.9%
16.6%
Q3 25
2.0%
14.8%
Q2 25
2.1%
14.8%
Q1 25
1.2%
15.7%
Q4 24
16.8%
15.1%
Q3 24
1.9%
12.8%
Q2 24
11.0%
13.7%
Cash Conversion
CPSH
CPSH
LIN
LIN
Q1 26
Q4 25
19.34×
1.98×
Q3 25
5.05×
1.53×
Q2 25
6.25×
1.25×
Q1 25
-13.05×
1.29×
Q4 24
1.63×
Q3 24
1.76×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons